Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

I.S.J. Merkies; J.P. Lawo; J.M. Edelman; J.L. De Bleecker; C. Sommer; W. Robberecht; M. Saarela; J. Kamienowski; Z. Stelmasiak; O. Mielke; B. Tackenberg; J.M. Leger; PRIMA Trial Investigators

doi:10.1111/jns.12204

Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

I.S.J. Merkies^*
, J.P. Lawo
, J.M. Edelman
, J.L. De Bleecker
, C. Sommer
, W. Robberecht
, M. Saarela
, J. Kamienowski
, Z. Stelmasiak
, O. Mielke
, B. Tackenberg
, J.M. Leger
, PRIMA Trial Investigators

^*Corresponding author for this work

MHeNs - Cognitive Neuropsychiatry and Clinical Neuroscience

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original language	English
Pages (from-to)	149-152
Number of pages	4
Journal	Journal of the Peripheral Nervous System
Volume	22
Issue number	2
DOIs	https://doi.org/10.1111/jns.12204
Publication status	Published - 1 Jun 2017

Keywords

INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY
INTRAVENOUS IMMUNOGLOBULIN
RASCH ANALYSES

Access to Document

10.1111/jns.12204Licence: CC BY

Cite this

Merkies, I. S. J., Lawo, J. P., Edelman, J. M., De Bleecker, J. L., Sommer, C., Robberecht, W., Saarela, M., Kamienowski, J., Stelmasiak, Z., Mielke, O., Tackenberg, B., Leger, J. M., & PRIMA Trial Investigators (2017). Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial. Journal of the Peripheral Nervous System, 22(2), 149-152. https://doi.org/10.1111/jns.12204

@article{a3f5e7ef26b343fb971cc99ce024011c,

title = "Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial",

keywords = "INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY, INTRAVENOUS IMMUNOGLOBULIN, RASCH ANALYSES",

author = "I.S.J. Merkies and J.P. Lawo and J.M. Edelman and \{De Bleecker\}, J.L. and C. Sommer and W. Robberecht and M. Saarela and J. Kamienowski and Z. Stelmasiak and O. Mielke and B. Tackenberg and J.M. Leger and \{PRIMA Trial Investigators\}",

year = "2017",

month = jun,

day = "1",

doi = "10.1111/jns.12204",

language = "English",

volume = "22",

pages = "149--152",

journal = "Journal of the Peripheral Nervous System",

issn = "1085-9489",

publisher = "Wiley-Blackwell",

number = "2",

}

Merkies, ISJ, Lawo, JP, Edelman, JM, De Bleecker, JL, Sommer, C, Robberecht, W, Saarela, M, Kamienowski, J, Stelmasiak, Z, Mielke, O, Tackenberg, B, Leger, JM & PRIMA Trial Investigators 2017, 'Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial', Journal of the Peripheral Nervous System, vol. 22, no. 2, pp. 149-152. https://doi.org/10.1111/jns.12204

TY - JOUR

T1 - Minimum clinically important difference analysis confirms the efficacy of IgPro10 in CIDP: the PRIMA trial

AU - Merkies, I.S.J.

AU - Lawo, J.P.

AU - Edelman, J.M.

AU - De Bleecker, J.L.

AU - Sommer, C.

AU - Robberecht, W.

AU - Saarela, M.

AU - Kamienowski, J.

AU - Stelmasiak, Z.

AU - Mielke, O.

AU - Tackenberg, B.

AU - Leger, J.M.

AU - PRIMA Trial Investigators

PY - 2017/6/1

Y1 - 2017/6/1

KW - INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY

KW - INTRAVENOUS IMMUNOGLOBULIN

KW - RASCH ANALYSES

U2 - 10.1111/jns.12204

DO - 10.1111/jns.12204

M3 - Comment/Letter to the editor

SN - 1085-9489

VL - 22

SP - 149

EP - 152

JO - Journal of the Peripheral Nervous System

JF - Journal of the Peripheral Nervous System

IS - 2

ER -